The change of retinal sensitivity with intravitreal injection of aflibercept for wet type of age-related macular degeneration.
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Dec 2015
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 01 Dec 2015 Planned initiation date changed from 1 Feb 2015 to 1 Feb 2016, according to University Hospital Medical Information Network - Japan.
- 06 Jan 2015 New trial record